PANBIO™ COVID-19 Ag Rapid Nasal Test Device

Description The PANBIO™ COVID-19 Ag Rapid Nasal Test Device is an in vitro immunochromatographic assay for the direct and qualitative detection of SARS-CoV-2 viral nucleoprotein antigens from nasal secretion samples. In just 15 minutes, individuals can determine a positive or negative result. If positive, individuals should adhere to their local public health guidelines and verify results with a PCR test.  Antigens are generally detectable in nasal secretions during the acute phase of infection. Positive results indicate the presence of viral antigens, but other diagnostic information is necessary to determine infection status. Negative results should be treated as presumptive, and do not rule out SARS-CoV-2 infection and should not be used as the sole basis for treatment or patient management decisions, including infection control decisions. Accessible, large-scale testing helps contain the virus spread.  It is the perfect screening tool for organizations that want to protect their w